Briviact

Medicinal product

(Invented) name

Briviact

Active substance (s)

Brivaracetamas

Strength

10 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N03AX23, Brivaracetam

Marketing authorisation holder

UCB Pharma S.A., Belgija

Date of authorisation

2016-01-14

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Brivaracetamas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
65022	79518	1079518	lizdinė plokštelė	N14		Receptinis	EU/1/15/1073/001	Netiekiama	-	-	No	-	-
65023	79519	1079519	lizdinė plokštelė	N56		Receptinis	EU/1/15/1073/002	Netiekiama	-	-	No	-	-
65024	79520	1079520	dalomoji lizdinė plokštelė	N100x1		Receptinis	EU/1/15/1073/003	Netiekiama	-	-	No	-	-
65025	79521	1079521	lizdinė plokštelė	N168 (3x56) (sudėtinė)		Receptinis	EU/1/15/1073/004	Netiekiama	-	-	No	-	-
65980	80494	1080494	dalomoji lizdinė plokštelė	N14x1		Receptinis	EU/1/15/1073/023	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2016-01-14	Registruotas